Jane Street Group, LLC Beam Therapeutics Inc. Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$53.73 - $82.16 $7.19 Million - $11 Million	133,800 Added 1393.75%	143,400 $8.22 Million
Q4 2021 Feb 15, 2022	SELL	$68.02 - $99.06 $1.54 Million - $2.25 Million	-22,700 Reduced 70.28%	9,600 $765,000
Q3 2021 Nov 16, 2021	SELL	$84.37 - $133.6 $168,740 - $267,200	-2,000 Reduced 5.83%	32,300 $2.81 Million
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $1.51 Million - $3.04 Million	23,600 Added 220.56%	34,300 $4.42 Million
Q1 2021 May 18, 2021	BUY	$71.28 - $120.75 $14,256 - $24,150	200 Added 1.9%	10,700 $856,000
Q4 2020 Feb 17, 2021	BUY	$22.24 - $95.63 $233,519 - $1 Million	10,500 New	10,500 $857,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.